Painreform is trading at $1.19 (-6.30%) following a sharp intraday selloff as the speculative momentum from its recent rally begins to fade.
- The stock previously surged on July 15 after joining the NVIDIA Connect Program for its AI solar unit, but there are no fresh company announcements to support today's price action.
- Broader market weakness and selling pressure in the biotech sector are likely contributing to the downward move.
- As a low-priced and highly volatile stock, price swings are often amplified when market sentiment shifts toward risk-off.